BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29280311)

  • 1. Fluorination Enhances Serum Stability of Bioreducible Poly(amido amine) Polyplexes and Enables Efficient Intravenous siRNA Delivery.
    Chen G; Wang K; Wang Y; Wu P; Sun M; Oupický D
    Adv Healthc Mater; 2018 Mar; 7(5):. PubMed ID: 29280311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining Fluorination and Bioreducibility for Improved siRNA Polyplex Delivery.
    Chen G; Wang K; Hu Q; Ding L; Yu F; Zhou Z; Zhou Y; Li J; Sun M; Oupický D
    ACS Appl Mater Interfaces; 2017 Feb; 9(5):4457-4466. PubMed ID: 28135066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversibly Stabilized Polycation Nanoparticles for Combination Treatment of Early- and Late-Stage Metastatic Breast Cancer.
    Chen G; Wang Y; Wu P; Zhou Y; Yu F; Zhu C; Li Z; Hang Y; Wang K; Li J; Sun M; Oupicky D
    ACS Nano; 2018 Jul; 12(7):6620-6636. PubMed ID: 29985577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of fluoroalkyl chain length and density on siRNA delivery of bioreducible poly(amido amine)s.
    Chen G; Wang Y; Ullah A; Huai Y; Xu Y
    Eur J Pharm Sci; 2020 Sep; 152():105433. PubMed ID: 32590121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physicochemical and biological evaluation of siRNA polyplexes based on PEGylated Poly(amido amine)s.
    Vader P; van der Aa LJ; Engbersen JF; Storm G; Schiffelers RM
    Pharm Res; 2012 Feb; 29(2):352-61. PubMed ID: 21833793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VEGF siRNA delivery system using arginine-grafted bioreducible poly(disulfide amine).
    Kim SH; Jeong JH; Kim TI; Kim SW; Bull DA
    Mol Pharm; 2009; 6(3):718-26. PubMed ID: 19055368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual-responsive polyplexes with enhanced disassembly and endosomal escape for efficient delivery of siRNA.
    Zhu J; Qiao M; Wang Q; Ye Y; Ba S; Ma J; Hu H; Zhao X; Chen D
    Biomaterials; 2018 Apr; 162():47-59. PubMed ID: 29432988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silica nanogelling of environment-responsive PEGylated polyplexes for enhanced stability and intracellular delivery of siRNA.
    Gouda N; Miyata K; Christie RJ; Suma T; Kishimura A; Fukushima S; Nomoto T; Liu X; Nishiyama N; Kataoka K
    Biomaterials; 2013 Jan; 34(2):562-70. PubMed ID: 23083934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complexation of Chol-DsiRNA in place of Chol-siRNA greatly increases the duration of mRNA suppression by polyplexes of PLL(30)-PEG(5K) in primary murine syngeneic breast tumors after i.v. administration.
    Ambardekar VV; Wakaskar RR; Ye Z; Curran SM; McGuire TR; Coulter DW; Singh RK; Vetro JA
    Int J Pharm; 2018 May; 543(1-2):130-138. PubMed ID: 29601972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combinatorial optimization of PEG architecture and hydrophobic content improves ternary siRNA polyplex stability, pharmacokinetics, and potency in vivo.
    Werfel TA; Jackson MA; Kavanaugh TE; Kirkbride KC; Miteva M; Giorgio TD; Duvall C
    J Control Release; 2017 Jun; 255():12-26. PubMed ID: 28366646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors influencing polycation/siRNA colloidal stability toward aerosol lung delivery.
    Steele TW; Zhao X; Tarcha P; Kissel T
    Eur J Pharm Biopharm; 2012 Jan; 80(1):14-24. PubMed ID: 21924355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conjugate Polyplexes with Anti-Invasive Properties and Improved siRNA Delivery In Vivo.
    Chen Y; Li J; Oupický D
    Bioconjug Chem; 2018 Feb; 29(2):296-305. PubMed ID: 29338191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiomyocyte-targeted siRNA delivery by prostaglandin E(2)-Fas siRNA polyplexes formulated with reducible poly(amido amine) for preventing cardiomyocyte apoptosis.
    Kim SH; Jeong JH; Ou M; Yockman JW; Kim SW; Bull DA
    Biomaterials; 2008 Nov; 29(33):4439-46. PubMed ID: 18725170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redox-responsive polymeric micelles formed by conjugating gambogic acid with bioreducible poly(amido amine)s for the co-delivery of docetaxel and MMP-9 shRNA.
    Kang Y; Lu L; Lan J; Ding Y; Yang J; Zhang Y; Zhao Y; Zhang T; Ho RJY
    Acta Biomater; 2018 Mar; 68():137-153. PubMed ID: 29288085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly Efficient and Safe Delivery of VEGF siRNA by Bioreducible Fluorinated Peptide Dendrimers for Cancer Therapy.
    Cai X; Zhu H; Zhang Y; Gu Z
    ACS Appl Mater Interfaces; 2017 Mar; 9(11):9402-9415. PubMed ID: 28228013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A hierarchical assembly strategy to engineer dextran-enveloped polyurethane nanopolyplexes for robust ovarian cancer gene therapy.
    Lou B; Jin R; Cheng J; Wen X; Zhao P; Lin C
    Acta Biomater; 2018 Sep; 78():260-273. PubMed ID: 30071349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of polyethylene glycol chain length on the physicochemical and biological properties of poly(ethylene imine)-graft-poly(ethylene glycol) block copolymer/SiRNA polyplexes.
    Mao S; Neu M; Germershaus O; Merkel O; Sitterberg J; Bakowsky U; Kissel T
    Bioconjug Chem; 2006; 17(5):1209-18. PubMed ID: 16984130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of three ternary complexes prepared in different mixing orders of siRNA/redox-responsive hyperbranched poly (amido amine)/hyaluronic acid.
    Chen CJ; Zhao ZX; Wang JC; Zhao EY; Gao LY; Zhou SF; Liu XY; Lu WL; Zhang Q
    Int J Nanomedicine; 2012; 7():3837-49. PubMed ID: 22888238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbohydrate-interactive pDNA and siRNA gene vectors based on boronic acid functionalized poly(amido amine)s.
    Piest M; Ankoné M; Engbersen JF
    J Control Release; 2013 Aug; 169(3):266-75. PubMed ID: 23428840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-PEGylation of siRNA Lipo-oligoamino Amide Polyplexes Using Tetra-glutamylated Folic Acid as Ligand for Receptor-Targeted Delivery.
    Müller K; Kessel E; Klein PM; Höhn M; Wagner E
    Mol Pharm; 2016 Jul; 13(7):2332-45. PubMed ID: 27177200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.